TROMBÓLISE EM TROMBOEMBOLISMO PULMONAR DE RISCO INTERMEDIÁRIO

Autores

  • Valéria Cristina Scavasine Universidade Federal do Paraná - UFPR
  • Fernando Michiellin Universidade Federal do Paraná - UFPR
  • Anderson Roberto Dallazen Universidade Federal do Paraná - UFPR
  • Gustavo Lenci Marques Universidade Federal do Paraná - UFPR
  • Maurício Carvalho Universidade Federal do Paraná - UFPR

DOI:

https://doi.org/10.5380/rmu.v1i3.40812

Palavras-chave:

Trombolise, Embolia Pulmonar

Resumo

Tromboembolismo pulmonar (TEP) submaciço caracteriza-se por disfunção ventricular direita ou elevação de marcadores de necrose miocárdica em pacientes normotensos. A melhor terapêutica para esses casos permanece controversa. Há evidências recentes na literatura apontando para o benefício da terapia com fibrinolítico em pacientes com baixo risco de sangramento. Apresentamos o caso de uma jovem de 17 anos com TEP submaciço, submetida a trombólise com alteplase, com excelente evolução clínica.

Referências

Choi WH, Kwon SU, Jwa YJ et al. The pulmonary embolism severity in-dex in predicting the prognosis of patients with pulmonary embolism. Korean J Intern Med. 2009 Jun;24(2):123-7.

Daniels LB, Parker JA, Patel SR, Grodstein F. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embo-lism. Am J Cardiol 1997;80:184-8.

Howard LS, Hughes RJ. NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. Thorax. 2013 Apr;68(4):391-3.

Jaff MR, McMurtry MS, Archer SL et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011 April 26;123(16):1788-830.

Konstantinides S. Acute pulmonar embolism. N Engl J Med 2008; 359:2804-13.

Meyer G, Vicaut E, Danays T et al. Fibrinolysis for patients with inter-mediate-risk pulmonary embolism. N Engl J Med. 2014 Apr 10;370(15):1402-11.

Pomero F, Ageno W, Serraino C et al. The role of inherited thrombophil-ia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature. Thromb Res. 2014 Jul;134(1):84-9.

Silverstein MD1, Heit JA, Mohr DN et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998 Mar 23;158(6):585-93.

Torbicki A, Perrier A, Konstantinides SV, et al. Guidelines on the diagno-sis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-315.

Spencer FA1, Emery C, Lessard D et al. The Worcester Venous Throm-boembolism Study A Population-Based Study of the Clinical Epidemi-ology of Venous Thromboembolism. J Gen Intern Med. Jul 2006; 21(7): 722–727.

Downloads

Como Citar

Scavasine, V. C., Michiellin, F., Dallazen, A. R., Marques, G. L., & Carvalho, M. (2014). TROMBÓLISE EM TROMBOEMBOLISMO PULMONAR DE RISCO INTERMEDIÁRIO. Revista Médica Da UFPR, 1(3), 118–121. https://doi.org/10.5380/rmu.v1i3.40812

Edição

Seção

Journal Club